Delhi to shut Covaxin jab centres for 18-plus if stocks not refilled: AAP

AAP leader Atishi said the Delhi government will have to close vaccination centres where Covaxin is being administered to beneficiaries in the 18-44 age group after Tuesday evening

Covaxin
Covaxin
Press Trust of India New Delhi
1 min read Last Updated : May 10 2021 | 7:16 PM IST

AAP leader Atishi Monday said the Delhi government will have to close vaccination centres where Covaxin is being administered to beneficiaries in the 18-44 age group after Tuesday evening if its stocks are not replenished.

Delhi's Covaxin stock for this category would last till Tuesday evening, she said, adding Covishield doses for this age group can last up to four days.

"On Monday morning, Delhi had 2.74 lakh vaccine doses for people in the 18-plus category," she said, releasing the city's Vaccination Bulletin'.

"After Tuesday evening, the Delhi government will have to start closing down the vaccination centres where Covaxin is being administered (to the 18-44 age group). We will also have to shut down Covishield inoculation centres after four days," she said.

She said the Delhi government has already placed a purchase order for 1.34 crore vaccine doses with both manufacturers -- Bharat Biotech and Serum Institute of India.

"We hope that the Central government make more vaccine available soon," she added.

Delhi vaccinated over 1.28 lakh people against coronavirus on Saturday, while around 39 lakh doses have been administered in the national capital so far, she said.

No vaccination took place on Sunday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineAAP

First Published: May 10 2021 | 7:11 PM IST

Next Story